Ridgefield, CT, United States of America

Kevin Paul Julier


Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022

where 'Filed Patents' based on already Granted Patents

2 patents (USPTO):

Title: Kevin Paul Julier: Innovator in Medical Treatment Management

Introduction

Kevin Paul Julier is a notable inventor based in Ridgefield, Connecticut. He has made significant contributions to the field of medical treatment management through his innovative patents. With a total of two patents to his name, Julier is recognized for his work that bridges the gap between natural and modern medicines.

Latest Patents

Julier's latest patents include techniques for identifying potential medicinal interactions for online clinical trial study groups. This patent provides methods for analyzing interactions between natural and modern medicines for treating various conditions. It involves creating a mapping system that connects natural medicines to modern treatments, facilitating participation in clinical trials based on users' medication profiles. His other patent focuses on medical treatment management, where medical data is received to identify a user's medical condition. It analyzes object data from the user's vicinity to recommend medical procedures that utilize specific objects to address the identified condition.

Career Highlights

Kevin Paul Julier is currently employed at International Business Machines Corporation, commonly known as IBM. His work at IBM has allowed him to further develop his innovative ideas and contribute to advancements in medical technology.

Collaborations

Some of his notable coworkers include Anca Sailer and Ajay Mohindra, who have collaborated with him on various projects within the company.

Conclusion

Kevin Paul Julier's contributions to medical treatment management and his innovative patents highlight his role as a significant inventor in the field. His work continues to influence the integration of natural and modern medicines, paving the way for improved medical practices.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…